Anti-FAT2/ CDHF8/ CDHR9 monoclonal antibody
Anti-FAT2/ CDHF8/ CDHR9 antibody for FACS & in-vivo assay
Go to FAT2/FAT2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0434-Ab-1/ GM-Tg-hg-MP0434-Ab-2 | Anti-Human FAT2 monoclonal antibody | Human |
GM-Tg-rg-MP0434-Ab-1/ GM-Tg-rg-MP0434-Ab-2 | Anti-Rat FAT2 monoclonal antibody | Rat |
GM-Tg-mg-MP0434-Ab-1/ GM-Tg-mg-MP0434-Ab-2 | Anti-Mouse FAT2 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0434-Ab-1/ GM-Tg-cynog-MP0434-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FAT2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0434-Ab-1/ GM-Tg-felg-MP0434-Ab-2 | Anti-Feline FAT2 monoclonal antibody | Feline |
GM-Tg-cang-MP0434-Ab-1/ GM-Tg-cang-MP0434-Ab-2 | Anti-Canine FAT2 monoclonal antibody | Canine |
GM-Tg-bovg-MP0434-Ab-1/ GM-Tg-bovg-MP0434-Ab-2 | Anti-Bovine FAT2 monoclonal antibody | Bovine |
GM-Tg-equg-MP0434-Ab-1/ GM-Tg-equg-MP0434-Ab-2 | Anti-Equine FAT2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0434-Ab-1/ GM-Tg-hg-MP0434-Ab-2; GM-Tg-rg-MP0434-Ab-1/ GM-Tg-rg-MP0434-Ab-2; GM-Tg-mg-MP0434-Ab-1/ GM-Tg-mg-MP0434-Ab-2; GM-Tg-cynog-MP0434-Ab-1/ GM-Tg-cynog-MP0434-Ab-2; GM-Tg-felg-MP0434-Ab-1/ GM-Tg-felg-MP0434-Ab-2; GM-Tg-cang-MP0434-Ab-1/ GM-Tg-cang-MP0434-Ab-2; GM-Tg-bovg-MP0434-Ab-1/ GM-Tg-bovg-MP0434-Ab-2; GM-Tg-equg-MP0434-Ab-1/ GM-Tg-equg-MP0434-Ab-2 |
Products Name | Anti-FAT2 monoclonal antibody |
Format | mab |
Target Name | FAT2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-FAT2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species FAT2/ CDHF8/ CDHR9 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP0434 |
Target Name | FAT2 |
Gene ID | 2196,245827,65048,713698,479323,101084423,523046,100071515 |
Gene Symbol and Synonyms | CDHF8,CDHR9,EMI2,FAT2,Fath2,Gm523,HFAT2,MEGF1,mKIAA0811,SCA45 |
Uniprot Accession | Q9NYQ8,O88277 |
Uniprot Entry Name | FAT2_HUMAN,FAT2_RAT |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000086570 |
Target Classification | Tumor-associated antigen (TAA) |
The target: FAT2, gene name: FAT2, also named as CDHF8, CDHR9, HFAT2, MEGF1, SCA45. This gene is the second identified human homolog of the Drosophila fat gene, which encodes a tumor suppressor essential for controlling cell proliferation during Drosophila development. The gene product is a member of the cadherin superfamily, a group of integral membrane proteins characterized by the presence of cadherin-type repeats. In addition to containing 34 tandem cadherin-type repeats, the gene product has two epidermal growth factor (EGF)-like repeats and one laminin G domain. This protein most likely functions as a cell adhesion molecule, controlling cell proliferation and playing an important role in cerebellum development. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.